Transfusional Iron Overload
Showing NaN - NaN of 7
Transfusional Iron Overload, Beta-Thalassemia Trial in Worldwide (SPD602)
Terminated
- Transfusional Iron Overload
- Beta-Thalassemia
-
Boston, Massachusetts
- +8 more
Jun 10, 2021
Transfusional Iron Overload, Beta-thalassemia Trial in Worldwide (SPD602 (FBS0701, SSP-004184))
Completed
- Transfusional Iron Overload
- Beta-thalassemia
- SPD602 (FBS0701, SSP-004184)
-
Oakland, California
- +8 more
May 30, 2021
ß-thalassemia, Transfusional Iron Overload Trial in Cagliari, Genova, Orbassano (Deferasirox)
Completed
- β-thalassemia
- Transfusional Iron Overload
-
Cagliari, CA, Italy
- +2 more
Dec 6, 2020
Transfusional Iron Overload, ß-thalassemia Major, Pediatric Rare Anemia Trial in France, Italy (Deferasirox)
Completed
- Transfusional Iron Overload
- +2 more
-
Lyon, France
- +3 more
Feb 12, 2017
Transfusional Iron Overload, Transfusional Hemosiderosis Trial in Worldwide (Core Study: Deferasirox, Core Study: Deferoxamine,
Completed
- Transfusional Iron Overload
- Transfusional Hemosiderosis
- Core Study: Deferasirox
- +5 more
-
Toronto, Ontario, Canada
- +20 more
Aug 13, 2014